Mario Domenico Rizzato

6PUBLICATIONS
52CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 29, 2026
Unveiling the molecular profile of adenosquamous gallbladder carcinoma: characterization of a Caucasian cohort.

|Dec 30, 2025
FOLFOX Versus FOLFIRI as Second-Line Chemotherapy in Patients With Advanced Biliary Tract Cancers: A Multicenter, Italian Study.

Chiara Pircher, Federico Nichetti, Mario Domenico Rizzato

|Nov 21, 2025
Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study.

Federica Lo Prinzi, Federico Rossari, Antonio De Rosa

|Aug 26, 2025
Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World Study.

Monica Niger, Margherita Rimini, Florian Castet

|Sep 29, 2023
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract Cancers.

Tin-Yun Tang, Federico Nichetti, Ben Kaplan

|May 07, 2020
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study.

Andrea Casadei-Gardini, Giorgia Marisi, Vincenzo Dadduzio

Pageof 1

Frequent Collaborators

3 joint publications

Monica Niger

2 joint publications

Federico Nichetti

2 joint publications

Chiara Pircher

2 joint publications

Sara Lonardi